Strategy for diagnosis of congenital toxoplasmosis: Evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies

Journal of Clinical Microbiology

Volumn 39, Issue 6, 2001, Pages 2267-2271

  Pinon, J M ^a   Dumon, H ^a   Chemla, C ^a   Franck, J ^a   Petersen, E ^a   Lebech, M ^a   Zufferey, J ^a   Bessieres, M H ^a   Marty, P ^a   Holliman, R ^a   Johnson, J ^a   Luyasu, V ^a   Lecolier, B ^a   Guy, E ^a   Joynson, D H M ^a   Decoster, A ^a   Enders, G ^a   Pelloux, H ^a   Candolfi, E ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOFILTRATION ASSAY; EUROPE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMOSIS;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC TESTS; INFANT, NEWBORN; NEONATAL SCREENING; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

PROTOZOA; TOXOPLASMA;

EID: 0035008974     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.6.2267-2271.2001     Document Type: Article

References (35)

1. Congenital toxoplasmosis: Clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease
2. IgA antibody response during acquired and congenital toxoplasmosis
3. Détection des IgM spécifiques dans le diagnostic de la toxoplasmose congénitale par une méthode d'immunopture ELISA sur billes. Détermination des paramètres d'utilisation
4. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay
5. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods
6. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis
7. Detection of anti-toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis
8. Isolation of the parasite in congenital toxoplasmosis: Its practical and theoretical importance
9. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
10. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM
11. Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis
12. Study of developing clinical outbreak and serological rebounds in children with congenital toxoplasmosis and follow-up during the first 2 years of life
13. Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year
14. Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis
15. Apport du Western blot au diagnostic de la toxoplasmose congénitale
16. Congenital toxoplasmosis: Specific IgM in fetal blood, cord blood and in the newborn
17. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures
18. Méthodes d'évaluation des épreuves diagnostiques
19. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid
20. Congenital infection with Toxoplasma gondii
21. Prenatal diagnosis of congenital toxoplasmosis in 261 pregnancies
22. Naturally occurring immunoglobulin M antibodies to Toxoplasma gondii in Japanese populations
23. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis
24. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial
25. Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulin G, M, and A antibodies at different stages of infection
26. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis
27. Early neonatal diagnosis of congenital toxoplasmosis: Value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies
28. Interêt des profils immunologiques comparés E.L.I.F.A. dans le diagnostic précoce de la toxoplasmose congénitale
29. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns
30. Neurologic and developmental outcome in treated congenital toxoplasmosis
31. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: Follow-up of 78 cases between 1980 and 1997
32. Congenital toxoplasmosis: Value of prenatal treatment with pyrimethamine-sulfadoxine combination
33. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection
34. Toxoplasmosis in pregnancy
35. Epidemiology of toxoplasmosis: Worldwide status